⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1615519 | 1.00 | OPRM1 (0.31) | — | |
| SCHEMBL3585121 | 0.90 | DPP7 (0.41) | — | |
| SCHEMBL486412 | 0.87 | DPP7 (0.44) | — | |
| SCHEMBL1615523 | 0.84 | OPRM1 (0.39) | — | |
| SCHEMBL8557598 | 0.84 | KMT2A (0.37) | — | |
| SCHEMBL2116575 | 0.84 | SIGMAR1 (0.36) | — | |
| SCHEMBL1615233 | 0.82 | OPRM1 (0.48) | — | |
| SCHEMBL1615271 | 0.80 | OPRM1 (0.46) | — | |
| SCHEMBL1614359 | 0.80 | OPRM1 (0.46) | — | |
| SCHEMBL1614413 | 0.80 | OPRM1 (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1549761-A4 | METHODS AND COMPOSITIONS FOR THE MODIFICATION OF NUCLEIC ACIDS | VI TECHNOLOGIES INC (US) | 2006-02-15 | — | — | EP | disclosed |
| EP-1549761-A1 | METHODS AND COMPOSITIONS FOR THE MODIFICATION OF NUCLEIC ACIDS | V.I. Technologies, Inc. (US) | 2005-07-06 | — | — | EP | disclosed |
| WO-2005042060-A2 | METHOD AND COMPOSITION COMPRISING PYRUVATE, INOSINE, ADENINE, PHOSPHATE AND AN AZIRIDINO COMPOUND FOR TREATING A BIOLOGICAL SAMPLE | V.I. TECHNOLOGIES, INC. (US) | 2005-05-12 | — | — | WO | disclosed |
| US-20050074743-A1 | Method and composition for treating a biological sample | V.I. TECHNOLOGIES, INC. | 2005-04-07 | — | — | US | disclosed |
| WO-2005002570-A1 | USE OF AN AZIRIDINO COMPOUND TO SELECTIVELY INACTIVATE PARASITES IN BIOLOGICAL COMPOSITIONS | V.I. TECHNOLOGIES, INC. (US) | 2005-01-13 | — | — | WO | disclosed |
| EP-1451308-A4 | THERAPEUTIC USE OF AZIRIDINO COMPOUNDS | VI TECHNOLOGIES INC (US) | 2004-11-17 | — | — | EP | disclosed |
| EP-1451308-A2 | THERAPEUTIC USE OF AZIRIDINO COMPOUNDS | V.I. Technologies, Inc. (US) | 2004-09-01 | — | — | EP | disclosed |
| US-20040053208-A1 | Methods to selectively inactivate parasites in biological compositions | V. I. TECHNOLOGIES, Inc. (US) | 2004-03-18 | — | — | US | disclosed |
| WO-2003093512-A1 | METHODS AND COMPOSITIONS FOR THE MODIFICATION OF NUCLEIC ACIDS | V.I. TECHNOLOGIES, INC. (US) | 2003-11-13 | — | — | WO | disclosed |
| WO-2003066806-A2 | THERAPEUTIC USE OF AZIRIDINO COMPOUNDS | V.I. TECHNOLOGIES, INC. (US) | 2003-08-14 | — | — | WO | disclosed |